Indeed, CaM inhibitors showed a functional Sec62 knockdown by blocking Ca2+ efflux from the ER lumen [328] and inhibiting cancer cell migration in cervix and prostate cancer cells with inhibition of cancer cell proliferation at higher doses [328]. Here, SEC62 is linked to prostate cancer.